Zhuhai Beihai Biotech Co., Ltd
Quick facts
Phase 3 pipeline
- BH009 (Docetaxel injection) · Oncology
Docetaxel stabilizes microtubules by binding to β-tubulin, preventing their depolymerization and disrupting cell division.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Zhuhai Beihai Biotech Co., Ltd portfolio CI brief
- Zhuhai Beihai Biotech Co., Ltd pipeline updates RSS
Frequently asked questions about Zhuhai Beihai Biotech Co., Ltd
What is Zhuhai Beihai Biotech Co., Ltd's pipeline?
Zhuhai Beihai Biotech Co., Ltd has 1 drugs in Phase 3, 0 in Phase 2, 3 in Phase 1. Late-stage candidates include BH009 (Docetaxel injection).
Related
- Sector hub: All tracked pharma companies